NCT06932952
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06932952
Title A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR | ESP | BEL

Facility Status City State Zip Country Details
Institut Jules Bordet Brussels Belgium Details
UZ Leuven Leuven Belgium Details
CIOCC Hospital Universitario HM Sanchinarro Madrid Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid Spain Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
The Royal Marsden Sutton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field